Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.

David Alexander Leaf

Journal: The American journal of medicine 2008;121(1):10-2

PMID: 18187065

Full Text on Elsevier Science View on PubMed

Abstract

Chylomicronemia is present when triglyceride levels exceed 1000 mg/dL. Chylomicronemia, when accompanied by eruptive xanthoma, lipemia retinalis, or abdominal symptoms, is referred to as the "chylomicronemia syndrome" and can cause acute pancreatitis. Treatment aimed at reducing triglyceride levels includes lifestyle modifications to promote weight loss with diet and physical activity coupled with medications, including fibrates, n-3 polyunsaturated fatty acids, and nicotinic acid. Chylomicronemic patients with acute pancreatitis require insulinization in an inpatient setting to abolish chylomicronemia.

Address: Department of Medicine, UCLA School of Medicine, Los Angeles, California, USA. [email protected]

DOI: 10.1016/j.amjmed.2007.10.004

Link outs

Free resources

Medical:

https://medlineplus.gov/cholesterolmedicines.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Chylomicrons, Clofibric Acid, Diagnosis, Differential, Fatty Acids, Omega-3, Humans, Hypertriglyceridemia, Hypolipidemic Agents, Life Style, Syndrome, Triglycerides